Parallel Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$548K Sell
1,133
-109
-9% -$28.9K 0.01% 750
2026
Q1
$136K Sell
1,242
-1,209
-49% -$172K ﹤0.01% 1399
2025
Q4
$408K Buy
2,451
+850
+53% +$142K 0.01% 760
2025
Q3
$314K Buy
1,601
+459
+40% +$75.5K 0.01% 846
2025
Q2
$103K Buy
1,142
+449
+65% +$35.5K ﹤0.01% 1340
2025
Q1
$41.4K Sell
693
-45
-6% -$4.16K ﹤0.01% 1743
2024
Q4
$97.7K Buy
738
+362
+96% +$34K ﹤0.01% 1284
2024
Q3
$19.7K Buy
376
+126
+50% +$5.91K ﹤0.01% 2109
2024
Q2
$15.1K Hold
250
﹤0.01% 2134
2024
Q1
$18.5K Buy
+250
New +$18.5K ﹤0.01% 2021

Other funds holding ALAB

Parallel Advisors's ALAB Position: Q2 2026 in Review

Parallel Advisors reduced its Astera Labs (ALAB) stake by 8.8% in Q2 2026, selling an estimated $28.9K and leaving 1,133 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #750.

Parallel Advisors first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Parallel Advisors held 1,133 shares of Astera Labs worth $548K as of Q2 2026.
  • Parallel Advisors sold 109 Astera Labs shares in Q2 2026, an estimated $28.9K.
  • Astera Labs made up 0.01% of Parallel Advisors's portfolio in Q2 2026, its #750 holding.
  • Parallel Advisors first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.